fda category 2 bulk drug substances bpc 157 compounding list advisers back first four of seven unapproved peptides under review for looser rules FDA to Consider Lifting Restrictions

FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner BPC 157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with FDA's Overreach on Compounded Peptides

SKU: 31486875895 · From hgidocs.co